COTA expands clinicogenomics offering with Genomic Testing Cooperative partnership.
We combine oncology expertise with advanced technology and analytics to organize real world data in order to guide decisions and actions.
Together, we can bring clarity to cancer care.
We curate EHR data that can be used to drive research and standardization in order to improve patient outcomes while also reducing costs at your institution.
We make clinical sense of claims data, providing insight into performance and related outcomes across sites in order to support value-based payment models.
Our deeply curated real world data accelerates drug development informing the decisions and actions that will deliver the best drugs to patients faster and at a lower cost.
In the world of clinical trials, having a well-defined research question is key. And that’s where fit-for-purpose data sets come in. But what are the factors for defining research questions?
In this episode of the Real World Talk podcast, we get to hear from Seshamalini Srinivasan, Karla Feghali, Mandy Kelly, and Laura Fernandes. They talk about the criteria for defining research questions, the importance of fit-for-purpose data, and the other factors to consider in real-world data sources.
Let’s work together to transform cancer care.
